In this large, well-characterized patient cohort, we observed associations between circulating OPG and survival following a breast cancer diagnosis, with associations predominantly observed among women with hormone receptor-negative tumors, or those with tumors with discordant hormone receptor status and presumably not fully hormone responsive. The gene discussed is NR4A1; the disease is breast cancer.